id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-2802-0002,FDA,FDA-2017-D-2802,CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports Guidance for Industry,Other,Guidance,2017-08-09T04:00:00Z,2017,8,2017-08-09T04:00:00Z,2017-10-11T03:59:59Z,2024-11-07T01:03:34Z,,1,0,09000064829e8780
FDA-2017-D-2802-0001,FDA,FDA-2017-D-2802,"Chemistry, Manufacturing, and Controls Postapproval Manufacturing
Changes for Specified Biological Products To Be Documented in Annual
Reports; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2017-08-09T04:00:00Z,2017,8,2017-08-09T04:00:00Z,2017-10-11T03:59:59Z,2017-10-11T01:02:17Z,2017-16718,0,0,09000064829e7b45